Macro Group Pharmaceutical S.A.E. (MCRO) Key Statistics
24 reported figures for Macro Group Pharmaceutical S.A.E. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 4.23B
- P/B
- 5.29
- Dividend yield (FY 2022)
- 1.83%
Income (latest fiscal year)
- Revenue
- EGP 526.01M
- Net income
- EGP -272.65M
- EBITDA
- EGP -165.1M
- Free cash flow
- EGP -42.46M
- Profit margin
- -51.83%
Balance sheet
- Total assets
- EGP 513.69M
- Total debt
- EGP 50.03M
- Book value
- EGP 821.53M
Growth
- Revenue growth
- -27.91%
- Profit growth
- -256.84%
- EPS growth
- -259.13%
Per share
- EPS (fiscal year)
- -0.11
- Book value per share
- 0.24
- Dividend per share
- 0.023
- Return on equity
- -97.89%
- Return on assets
- -40%
Technical
- RSI (14)
- 41.3
- 50-day moving average
- EGP 1.51
- 200-day moving average
- EGP 1.36
- Beta (1Y)
- 0.7
Shares
- Shares outstanding
- 3.42B
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.